Cardiology Letters 2022, 31(3):196-201
Pulmonary embolism and Covid-19
- 1 Oddelenie kardiológie, FN Trnava
- 2 Rádiologická klinika, FN Trnava, Slovenská republika
Aims: Patients with pulmonary embolism (PE) have different in-hospital mortality rates depending on their comorbidities and the grade of the obstruction of the pulmonary artery. In this study, we observed whether Covid-19 infection had a worsening impact on prognosis in patients affected by PE. We also analysed the significance of known risk factors such as Troponin levels, NTproBNP levels, D-dimer, arterial blood lactate, and CRP levels in patients with Covid-19 associated PE.
Methods: In this prospective cohort study, we observed patients hospitalised during the second wave of the Covid-19 pandemic in Trnava. Patients were divided into two groups, 1. patients with covid-19 associated PE (Covid+), and 2. patients with PE without Covid-19 infection as a control group (Covid-). We compared clinical findings, imaging findings, laboratory results and in-hospital mortality between these two groups.
Results: In this prospective study, we analysed data from 74 patients. Median age of patients was 69.5 (IQR 58-77). We identified 26 (35%) Covid+ patients. Covid+ patients had a longer hospitalisation [11 (IQR 8-17) days vs 8 (IQR 6.25-10) days, p = 0.004] and significantly higher in-hospital mortality than Covid-group (23% vs 2%, p=0.0065). The combined risk of in-hospital mortality and hemodynamic decompensation was similar in both groups (23% vs 8%, P=0.15). Nonfatal bleeding was reported overall in 4 patients (5.4%) without any significant difference between the two groups (8% vs 4%, p=0,6). From laboratory tests, only NT-proBNP levels had shown the difference between our groups. Despite lower levels of NT-proBNP in Covid + group [300.5 (182-2755.5) vs 1372 (5405420.5) pg/ml, p = 0.03], mortality rate was higher in these patients.
Conclusion: The Covid+ group had significantly higher in-hospital mortality, which pointed out the negative impact of Covid-19 infection on patients with PE.
Keywords: Covid-19; pulmonary embolism; in-hospital mortality
Published: March 1, 2022 Show citation
References
- Pellicori P, Doolub G, Wong CM, Lee KS, Mangion K, Ahmad M, et al. COVID-19 and its cardiovascular effects: a systematic review of prevalence studies. Cochrane Database Syst Rev 2021;3:CD013879.
Go to original source... - Aujesky D, Obrosky DS, Stone RA, Auble TE, Perrier A, Cornuz J, et al. Derivation and validation of a prognostic model for pulmonary embolism. Am J Respir Crit Care Med 2005;172:1041-1046.
Go to original source... - Jiménez D, Aujesky D, Moores L, Go´mez V, Lobo JL, Uresandi F, et al. Simplification of the pulmonary embolism severity index for prognostication in patients with acute symptomatic pulmonary embolism. Arch Intern Med 2010;170:1383-1389.
Go to original source... - Konstantinides SV, Meyer G, Becattini C, Bueno H, Geersing GJ, Harjola VP, et al; ESC Scientific Document Group. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS). Eur Heart J. 2020;41:543-603.
Go to original source... - Lankeit M, Jimenez D, Kostrubiec M, et al. Validation of N-terminal pro-brain natriuretic peptide cut-off values for risk stratification of pulmonary embolism. Eur Respir J 2014;43:1669-1677.
Go to original source... - Schulman S, Kearon C. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in nonsurgicalpatients. J Thromb Haemost 2005;3:692-694.
Go to original source... - Anderson FA Jr, Spencer FA. Risk factors for venous thromboembolism. Circulation 2003;107 I9-I16.
Go to original source... - Mestre-Gómez B, et al. Incidence of pulmonary embolism in non-critically ill COVID-19 patients. Predicting factors for a challenging diagnosis. J. Thromb. Thrombolysis 2020;51:40-46.
Go to original source... - Benito, N. et al. Pulmonary thrombosis or embolism in a large cohort of hospitalized patients with covid-19. Front. Med. 2020;7:557.
Go to original source... - Fauvel C, et al. Pulmonary embolism in COVID-19 patients: A French multicentre cohort study. Eur. Heart J. 2020;41:3058-3068.
Go to original source... - Bobadilla-Rosado LO, Mier Y, Teran-Ellis S, Lopez-Pena G, AnayaAyala JE, Hinojosa CA. Clinical Outcomes of Pulmonary Embolism in Mexican Patients With COVID-19. Clin Appl Thromb Hemost. 2021 Jan-Dec; 27:10760296211008988. doi: 10.1177/10760296211008988
Go to original source... - Li P, Zhao W, Kaatz S, Latack K, Schultz L, Poisson L. Factors Associated With Risk of Postdischarge Thrombosis in Patients With COVID-19. JAMA Netw Open. 2021;4:e2135397
Go to original source...

